These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 22446323)

  • 1. CD25 is expressed by canine cutaneous mast cell tumors but not by cutaneous connective tissue mast cells.
    Meyer A; Gruber AD; Klopfleisch R
    Vet Pathol; 2012 Nov; 49(6):988-97. PubMed ID: 22446323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. All subunits of the interleukin-2 receptor are expressed by canine cutaneous mast cell tumours.
    Meyer A; Gruber AD; Klopfleisch R
    J Comp Pathol; 2013 Jul; 149(1):19-29. PubMed ID: 23276382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
    Vascellari M; Giantin M; Capello K; Carminato A; Morello EM; Vercelli A; Granato A; Buracco P; Dacasto M; Mutinelli F
    Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases and vascular endothelial growth factor in canine mast cell tumours.
    Giantin M; Aresu L; Benali S; Aricò A; Morello EM; Martano M; Vascellari M; Castagnaro M; Lopparelli RM; Zancanella V; Granato A; Mutinelli F; Dacasto M
    J Comp Pathol; 2012 Nov; 147(4):419-29. PubMed ID: 22520817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of molecular expression of KIT and KIT ligand analysed using real-time polymerase chain reaction and immunohistochemistry as a prognostic indicator for canine cutaneous mast cell tumours.
    Costa Casagrande TA; de Oliveira Barros LM; Fukumasu H; Cogliati B; Chaible LM; Dagli ML; Matera JM
    Vet Comp Oncol; 2015 Mar; 13(1):1-10. PubMed ID: 23294979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the aberrant expression of CD2 and CD25 by skin mast cells truly correlate with systemic involvement in patients presenting with mastocytosis in the skin?
    Lange M; Żawrocki A; Nedoszytko B; Wasąg B; Niedoszytko M; Jassem E; Nowicki R; Żmijewski MA; Biernat W
    Int Arch Allergy Immunol; 2014; 165(2):104-10. PubMed ID: 25402852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of stem cell factor in canine mast cell tumors.
    Amagai Y; Tanaka A; Jung K; Matsuda A; Oida K; Nishikawa S; Jang H; Ishizaka S; Matsuda H
    Res Vet Sci; 2014 Feb; 96(1):124-6. PubMed ID: 24269079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of proto-oncogene C-kit and correlation with morphological evaluations in canine cutaneous mast cell tumors.
    Passantino L; Passantino G; Cianciotta A; Ribaud MR; Lo Presti G; Ranieri G; Perillo A
    Immunopharmacol Immunotoxicol; 2008; 30(3):609-21. PubMed ID: 18608529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canine subcutaneous mast cell tumors: cellular proliferation and KIT expression as prognostic indices.
    Thompson JJ; Yager JA; Best SJ; Pearl DL; Coomber BL; Torres RN; Kiupel M; Foster RA
    Vet Pathol; 2011 Jan; 48(1):169-81. PubMed ID: 21160022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant autophosphorylation of c-Kit receptor in canine mast cell tumor cell lines.
    Takeuchi Y; Fujino Y; Watanabe M; Nakagawa T; Ohno K; Sasaki N; Sugano S; Tsujimoto H
    Vet Immunol Immunopathol; 2010 Oct; 137(3-4):208-16. PubMed ID: 20591500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the proteome of high-grade versus low-grade canine cutaneous mast cell tumours.
    Schlieben P; Meyer A; Weise C; Bondzio A; Einspanier R; Gruber AD; Klopfleisch R
    Vet J; 2012 Nov; 194(2):210-4. PubMed ID: 22578690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid sensitivity depends on expression levels of glucocorticoid receptors in canine neoplastic mast cells.
    Matsuda A; Tanaka A; Amagai Y; Ohmori K; Nishikawa S; Xia Y; Karasawa K; Okamoto N; Oida K; Jang H; Matsuda H
    Vet Immunol Immunopathol; 2011 Dec; 144(3-4):321-8. PubMed ID: 21908058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant canine IgE Fc and an IgE Fc-TRAIL fusion protein bind to neoplastic canine mast cells.
    Elders RC; Holder A; Smith KC; Baines SJ; Catchpole B
    Vet Immunol Immunopathol; 2014 May; 159(1-2):29-40. PubMed ID: 24690189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ c-KIT mRNA quantification of canine cutaneous mast cell tumours and its relationship to prognostic factors.
    Seung BJ; Cho SH; Kim SH; Bae MK; Lim HY; Sur JH
    Vet Comp Oncol; 2021 Mar; 19(1):132-139. PubMed ID: 32926564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-KIT messenger RNA and protein expression and mutations in canine cutaneous mast cell tumors: correlations with post-surgical prognosis.
    Giantin M; Vascellari M; Morello EM; Capello K; Vercelli A; Granato A; Lopparelli RM; Nassuato C; Carminato A; Martano M; Mutinelli F; Dacasto M
    J Vet Diagn Invest; 2012 Jan; 24(1):116-26. PubMed ID: 22362941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p62/Sequestosome-1: Mapping Sites of Protein-Handling Stress in Canine Cutaneous Mast Cell Tumors.
    Rich T; Dean RT; Lamm CG; Ramiro-Ibañez F; Stevenson ML; Patterson-Kane JC
    Vet Pathol; 2015 Jul; 52(4):621-30. PubMed ID: 25161207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of immunohistochemical expression of BAX in formulating a prognosis for canine cutaneous mast cell tumours.
    Strefezzi Rde F; Kleeb SR; Xavier JG; Fukumasu H; Catão-Dias JL
    J Comp Pathol; 2012 May; 146(4):314-9. PubMed ID: 21899858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E-cadherin in canine mast cell tumors: decreased expression and altered subcellular localization in Grade 3 tumors.
    Mackowiak II; Gentile LB; Chaible LM; Nagamine MK; Guerra JM; Mota EF; Matera JM; Mennecier G; Sanches DS; Dagli ML
    Vet J; 2012 Dec; 194(3):405-11. PubMed ID: 22766308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the KIT protein (CD117) in primary cutaneous mast cell tumors of the dog.
    Preziosi R; Morini M; Sarli G
    J Vet Diagn Invest; 2004 Nov; 16(6):554-61. PubMed ID: 15586571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of serotonin and its 5-HT1A receptor in canine cutaneous mast cell tumours.
    Fröberg GK; Lindberg R; Ritter M; Nordlind K
    J Comp Pathol; 2009; 141(2-3):89-97. PubMed ID: 19446835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.